BOTOX INNOTOX 50

Innotox 50 – The World’s First Liquid Botulinum Toxin Type A for Precision Aesthetic Use

1. Overview & Manufacturer
Innotox 50 is a botulinum toxin type A product developed by Medytox Inc., a globally recognized pharmaceutical company based in South Korea. What sets Innotox apart from other toxins is that it is the world’s first ready-to-use liquid formulation of botulinum toxin, eliminating the need for reconstitution with saline.

This makes Innotox 50 a highly convenient and time-efficient option for medical professionals, especially for targeted, low-dose aesthetic procedures.

---

2. Packaging & Composition

• Each vial contains 50 units of botulinum toxin type A in a pre-diluted, sterile liquid form.

• No reconstitution required, reducing handling error and contamination risk.

• Includes 0.9% sodium chloride, stabilizer, and no human serum albumin, making it safer for sensitive patients.

---

3. Mechanism of Action
Innotox functions by blocking the release of acetylcholine at the neuromuscular junction, temporarily inhibiting muscle contraction. This results in:

• Smoothing of expression lines and dynamic wrinkles

• Facial contouring through muscle relaxation

• Control of glandular hyperactivity (such as sweating)

---

4. Key Advantages

• ???? Liquid formulation: No dilution needed – quick, consistent, and ready to inject

• ???? Albumin-free: Uses a synthetic stabilizer instead of human serum albumin – lower allergenic risk

• ???? High stability: Can be stored at room temperature up to 25°C for several days

• ???? Precision dosing: Ideal for fine facial lines and first-time or younger patients needing smaller doses

• ✅ Consistent potency and results, with reduced risk of dosing error

---

5. Clinical Applications

• Aesthetic Indications:

  • Fine lines and wrinkles (forehead, glabella, crow’s feet)

  • Lip lines and perioral wrinkles

  • Bunny lines and chin dimpling

  • Eyebrow lift and facial shaping

• Medical Use (off-label):

  • Mild cases of hyperhidrosis

  • Muscle twitching or facial spasms (low-dose treatments)

---

6. Safety & Approval

• Approved by the Korean MFDS (Ministry of Food and Drug Safety)

• Manufactured under strict GMP compliance

• Widely used throughout Asia, Latin America, and the Middle East

• Low immunogenicity and high safety profile

---

7. Storage & Handling

• Refrigeration (2–8°C) is recommended for long-term storage

• May be stored at room temperature (≤25°C) for a limited period per manufacturer’s guidelines

• Should only be administered by licensed medical professionals